Article Details
Retrieved on: 2019-02-26 02:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>PRINCETON, NJ — Oyster Point Pharma Inc., a pharmaceutical company developing therapies for dry eye disease, has raised $93 million in funding.</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here